M RIPRETINIB (is an active metabolite) | RIPRETINIB | ATC L01EX19
ANTINEOPLASTIC KIT PROTO-ONCOGENE RECEPTOR TYROSINE KINASE INHIBITOR PLATELET DERIVED GROWTH FACTOR RECEPTOR A (PDGFRA) INHIBITOR TREATMENT OF ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) INHIBITS PDGFRB, TIE2, VEGFR2, AND BRAF | - | Cmax 1.62 MICROMOLAR Tmax 15.6 HOUR VD 507 LITER PPB 99.8 PERCENT Cl 17.5 LITER / HOUR HT 17.8 HOUR | PROTO-ONCOGENE RECEPTOR TYROSINE KINASE (KIT) | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |